Strategies in the Global Tumor Marker Testing Market 2015 - Analyzes Applications of Emerging Diagnostic Technologies.

Aug 13, 2015, 12:10 ET from Research and Markets

DUBLIN, Aug. 13, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/xx9ffg/2015_strategies) has announced the addition of the "2015 Strategies in the Global Tumor Marker Testing Market: US, Europe, Japan" report to their offering.

Highlights

Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years.

Examines trends in the U.S., Europe and Japan Reviews current and emerging tumor markers.

Analyzes applications of emerging diagnostic technologies.

Forecasts sales of major tumor markers by country and market segment.

Profiles leading market players and potential entrants

Companies Mentioned:

  • Abbott
  • AdnaGen
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Correlogic Systems/Vermillion
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Epigenomics
  • Enterix
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio/Innogenetics
  • Guided Therapeutics
  • Hologic/Gen-Probe
  • Kreatech
  • Kyowa Medex
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics

For more information visit http://www.researchandmarkets.com/research/xx9ffg/2015_strategies

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com